C

Cellics Therapeutics, Inc.

22 employees

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.

Basic info

biotechnology research

Biotechnology

CRS

Coronavirus

Biologics

IBD

Health Care

Sepsis

Inflammatory Diseases

Therapeutics

Infectious Diseases

Cell Membrane Coating

Macrophage

Rhumatoid Arthritis

Nanoparticles

MRSA Pneumonia

2014

$3.9M

from 1 investors over 1 rounds

C

Cellics Therapeutics, Inc. raised $3.9M on October 21, 2020

Investors: CARB-X